Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies

Cancer Epidemiology

Volumn 40, Issue , 2016, Pages 39-46

  Søreide, Kjetil ^a,b   Sandvik, Oddvar M ^a   Søreide, Jon Arne ^a,b   Giljaca, Vanja ^c   Jureckova, Andrea ^d   Bulusu, V Ramesh ^e  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c KBC RIJEKA   (Croatia)

^d MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^e CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Distribution; Epidemiology; GIST; Incidence; Registry; Risk category

Indexed keywords

CANCER INCIDENCE; CHINA; GASTROINTESTINAL STROMAL TUMOR; HUMAN; INCIDENTAL FINDING; NORWAY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; REGISTER; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; TAIWAN; TUMOR LOCALIZATION; ADOLESCENT; ADULT; AGED; FEMALE; GASTROINTESTINAL STROMAL TUMORS; INCIDENCE; MALE; MIDDLE AGED; RISK ASSESSMENT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK ASSESSMENT; YOUNG ADULT;

EID: 84960091691     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.10.031     Document Type: Review

References (78)

1. Rubin B.P., Heinrich M.C., Corless C.L. Gastrointestinal stromal tumour. Lancet 2007, 369:1731-1741.
2. Hirota S., Isozaki K., Moriyama Y., Hashimoto K., Nishida T., Ishiguro S., et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998, 279:577-580.
3. Heinrich M.C., Corless C.L., Duensing A., McGreevey L., Chen C.J., Joseph N., et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003, 299:708-710.
4. Joensuu H., Roberts P.J., Sarlomo-Rikala M., Andersson L.C., Tervahartiala P., Tuveson D., et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N. Engl. J. Med. 2001, 344:1052-1056.
5. van Oosterom A.T., Judson I., Verweij J., Stroobants S., Donato di Paola E., Dimitrijevic S., et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 2001, 358:1421-1423.
6. Nilsson B., Andersson A., Ahlman H. Adjuvant and down-staging treatment with imatinib in gastrointestinal stromal tumors. J. Surg. Oncol. 2008, 98:145-146.
7. Dematteo R.P., Ballman K.V., Antonescu C.R., Maki R.G., Pisters P.W., Demetri G.D., et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet 2009, 373:1097-1104.
8. Ruka W., Rutkowski P., Szawlowski A., Nowecki Z., Debiec-Rychter M., Grzesiakowska U., et al. Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib. Eur. J. Surg. Oncol. 2009, 35:87-91.
9. Dudeja V., Armstrong L.H., Gupta P., Ansel H., Askari S., Al-Refaie W.B. Emergence of imatinib resistance associated with downregulation of c-kit expression in recurrent gastrointestinal stromal tumor (GIST): optimal timing of resection. J. Gastrointest. Surg. 2010, 14:557-561.
10. Raut C.P., Wang Q., Manola J., Morgan J.A., George S., Wagner A.J., et al. Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate. Ann. Surg. Oncol. 2010, 17:407-415.
11. Nilsson B., Nilsson O., Ahlman H. Treatment of gastrointestinal stromal tumours: imatinib, sunitinib-and then?. Expert. Opin. Invest. Drugs 2009, 18:457-468.
12. Kingham T.P., DeMatteo R.P. Multidisciplinary treatment of gastrointestinal stromal tumors. Surg. Clin. North Am. 2009, 89:217-233. x.
13. Chaudhry U.I., DeMatteo R.P. Management of resectable gastrointestinal stromal tumor. Hematol. Oncol. Clin. North Am. 2009, 23:79-96. viii.
14. Gold J.S., Dematteo R.P. Neoadjuvant therapy for gastrointestinal stromal tumor (GIST): racing against resistance. Ann. Surg. Oncol. 2007, 14:1247-1248.
15. Steigen S.E., Eide T.J. Gastrointestinal stromal tumors (GISTs): a review. APMIS 2009, 117:73-86.
16. Liegl-Atzwanger B., Fletcher J.A., Fletcher C.D. Gastrointestinal stromal tumors. Virchows Arch. 2010, 456:111-127.
17. Fletcher C.D., Berman J.J., Corless C., Gorstein F., Lasota J., Longley B.J., et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum. Pathol. 2002, 33:459-465.
18. Miettinen M., Wang Z.F., Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am. J. Surg. Pathol. 2009, 33:1401-1408.
19. DeMatteo R.P., Lewis J.J., Leung D., Mudan S.S., Woodruff J.M., Brennan M.F. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann. Surg. 2000, 231:51-58.
20. Miettinen M., Sobin L.H., Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am. J. Surg. Pathol. 2005, 29:52-68.
21. Miettinen M., Makhlouf H., Sobin L.H., Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am. J. Surg. Pathol. 2006, 30:477-489.
22. Gold J.S., Gonen M., Gutierrez A., Broto J.M., Garcia-del-Muro X., Smyrk T.C., et al. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol. 2009, 10:1045-1052.
23. Tran T., Davila J.A., El-Serag H.B. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1458 cases from 1992 to 2000. Am. J. Gastroenterol. 2005, 100:162-168.
24. Blanke C., Eisenberg B.L., Heinrich M. Epidemiology of GIST. Am. J. Gastroenterol. 2005, 100:2366.
25. Bank W., 2014. http://data.worldbank.org/indicator/SP.POP.TOTL.
26. Nilsson B., Bumming P., Meis-Kindblom J.M., Oden A., Dortok A., Gustavsson B., et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden. Cancer 2005, 103:821-829.
27. Tryggvason G., Gislason H.G., Magnusson M.K., Jonasson J.G. Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int. J. Cancer 2005, 117:289-293.
28. Goettsch W.G., Bos S.D., Breekveldt-Postma N., Casparie M., Herings R.M., Hogendoorn P.C. Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study. Eur. J. Cancer 2005, 41:2868-2872.
29. Kim K.M., Kang D.W., Moon W.S., Park J.B., Park C.K., Sohn J.H., et al. Gastrointestinal stromal tumors in Koreans: it's incidence and the clinical, pathologic and immunohistochemical findings. J. Korean Med. Sci. 2005, 20:977-984.
30. Steigen S.E., Eide T.J. Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of northern Norway. APMIS 2006, 114:192-200.
31. Chan K.H., Chan C.W., Chow W.H., Kwan W.K., Kong C.K., Mak K.F., et al. Gastrointestinal stromal tumors in a cohort of Chinese patients in Hong Kong. World J. Gastroenterol. 2006, 12:2223-2228.
32. Perez E.A., Livingstone A.S., Franceschi D., Rocha-Lima C., Lee D.J., Hodgson N., et al. Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J. Am. Coll. Surg. 2006, 202:623-629.
33. Rubio J., Marcos-Gragera R., Ortiz M.R., Miro J., Vilardell L., Girones J., et al. Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain. Eur. J. Cancer 2007, 43:144-148.
34. Mucciarini C., Rossi G., Bertolini F., Valli R., Cirilli C., Rashid I., et al. Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer 2007, 7:230.
35. Tzen C.Y., Wang J.H., Huang Y.J., Wang M.N., Lin P.C., Lai G.L., et al. Incidence of gastrointestinal stromal tumor: a retrospective study based on immunohistochemical and mutational analyses. Dig. Dis. Sci. 2007, 52:792-797.
36. Mazzola P., Spitale A., Banfi S., Mazzucchelli L., Frattini M., Bordoni A. Epidemiology and molecular biology of gastrointestinal stromal tumors (GISTs): a population-based study in the South of Switzerland, 1999-2005. Histol Histopathol. 2008, 23:1379-1386.
37. Ahmed I., Welch N.T., Parsons S.L. Gastrointestinal stromal tumours (GIST)-17 years experience from Mid Trent Region (United Kingdom). Eur. J. Surg. Oncol. 2008, 34:445-449.
38. Yan B.M., Kaplan G.G., Urbanski S., Nash C.L., Beck P.L. Epidemiology of gastrointestinal stromal tumors in a defined Canadian Health Region: a population-based study. Int. J. Surg. Pathol. 2008, 16:241-250.
39. Brabec P., Sufliarsky J., Linke Z., Plank L., Mrhalova M., Pavlik T., et al. A whole population study of gastrointestinal stromal tumors in the Czech Republic and Slovakia. Neoplasma 2009, 56:459-464.
40. Cassier P.A., Ducimetiere F., Lurkin A., Ranchere-Vince D., Scoazec J.Y., Bringuier P.P., et al. A prospective epidemiological study of new incident GISTs during two consecutive years in Rhone Alpes region: incidence and molecular distribution of GIST in a European region. Br. J. Cancer 2010, 103:165-170.
41. Monges G., Bisot-Locard S., Blay J.Y., Bouvier A.M., Urbieta M., Coindre J.M., et al. The estimated incidence of gastrointestinal stromal tumors in France: results of PROGIST study conducted among pathologists. Bull. du Cancer 2010, 97:E16-22.
42. Cho M.Y., Sohn J.H., Kim J.M., Kim K.M., Park Y.S., Kim W.H., et al. Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004. J. Korean Med. Sci. 2010, 25:853-862.
43. Hartley R.J., Becker J.H., Van der Walt H., Luvhengo T. Gastro-intestinal stromal tumours (GISTs) - the Pretoria experience and a literature review. South Afr. J. Surg. Suid-Afrikaanse tydskrif vir chirurgie 2011, 49:128-131.
44. Sandvik O.M., Søreide K., Kvaløy J.T., Gudlaugsson E., Søreide J.A. Epidemiology of gastrointestinal stromal tumours: single-institution experience and clinical presentation over three decades. Cancer Epidemiol. 2011, 35:515-520.
45. Giljaca V., Grohovac D., Kovac D., Stimac D. Gastrointestinal stromal tumors characteristics in Croatian Northern Adriatic region. Hepatogastroenterology. 2012, 59:2512-2515.
46. Mastrangelo G., Coindre J.M., Ducimetiere F., Dei T., os A.P., Fadda E., Blay J.Y., et al. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer 2012, 118:5339-5348.
47. Manrique M.N., Soriano C., Yabar A., Frisancho O., Palacios A.M. Gastrointestinal stromal tumors: clinicopathologic and survival evaluation in Rebagliati Hospital. Revista de gastroenterologia del Peru: organo oficial de la Sociedad de Gastroenterologia del Peru 2012, 32:357-365.
48. Wang Z.H., Liang X.B., Wang Y., Ma G.L., Qu Y.Q., Tian X.W. Epidemiology survey of gastrointestinal stromal tumor in Shanxi Province in 2011. Zhonghua yi xue za zhi 2013, 93:2541-2544.
49. Minarik G., Plank L., Lasabova Z., Szemes T., Burjanivova T., Szepe P., et al. Spectrum of mutations in gastrointestinal stromal tumor patients-a population-based study from Slovakia. APMIS 2013, 121:539-548.
50. Rubió-Casadevall J., Borràs J.L., Carmona C., Ameijide A., Osca G., Vilardell L., Izquierdo A., Galceran J., Marcos-Gragera R. Temporal trends of incidence andsurvival of sarcoma of digestive tract including Gastrointestinal Stromal Tumours (GIST) in two areas of the north-east of Spain in the period 1981-2005: a population-based study. Clin. Transl. Oncol. 2014, 16(7):660-667.
51. Jureckova A., Kocakova I., Vyzula R. GIST registry. Klinicka onkologie: casopis Ceske a Slovenske onkologicke spolecnosti 2012, 25:135-138.
52. Chiang N.J., Chen L.T., Tsai C.R., Chang J.S. The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998-2008: a nation-wide cancer registry-based study. BMC Cancer 2014, 14:102.
53. Lv M., Wu C., Zheng Y., Zhao N. Incidence and survival analysis of gastrointestinal stromal tumors in shanghai: a population-based study from 2001 to 2010. Gastroenterol. Res. Pract. 2014, 2014:834136.
54. Choi A.H., Hamner J.B., Merchant S.J., Trisal V., Chow W., Garberoglio C.A., et al. Underreporting of gastrointestinal stromal tumors: is the true incidence being captured?. J. Gastrointest. Surg. 2015, 19:1699-1703.
55. Agaimy A., Wunsch P.H., Hofstaedter F., Blaszyk H., Rummele P., Gaumann A., et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am. J. Surg. Pathol. 2007, 31:113-120.
56. Stiller C.A., Trama A., Serraino D., Rossi S., Navarro C., Chirlaque M.D., et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur. J. Cancer 2013, 49:684-695.
57. Bulusu V.R., Fullarton J., Leahy M., Morgan C., Rasheed A., Taniere P., et al. Rationale and design of a UK database for a rare cancer type: the GEM registry for gastrointestinal stromal tumours. Br. J. Cancer 2013, 109:1403-1407.
58. Pisters P.W., Blanke C.D., von M., ehren M., Picus J., Sirulnik A., Stealey E., et al. A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices. Ann. Oncol. 2011, 22:2523-2529.
59. Neuville A., Ranchere-Vince D., Dei Tos A.P., Montesco M.C., Hostein I., Toffolatti L., et al. Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study. Am. J. Surg. Pathol. 2013, 37:1259-1268.
60. Rubin B.P., Blanke C.D., Demetri G.D., Dematteo R.P., Fletcher C.D., Goldblum J.R., et al. Protocol for the examination of specimens from patients with gastrointestinal stromal tumor. Arch. Pathol. Lab Med. 2010, 134:165-170.
61. Ma G.L., Murphy J.D., Martinez M.E., Sicklick J.K. Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study. Cancer Epidemiol. Biomarkers Prev. 2015, 24(1):298-302.
62. Yuval J.B., Khalaileh A., Abu-Gazala M., Shachar Y., Keidar A., Mintz Y., et al. The true incidence of gastric GIST-a study based on morbidly obese patients undergoing sleeve gastrectomy. Obesity Surg. 2014, 24:2134-2137.
63. Yamamoto K., Tsujinaka T., Takahashi T., Sato S., Nishiguchi Y., Nakashima Y., et al. Impact of the Japanese gastric cancer screening system on treatment outcomes in gastric gastrointestinal stromal tumor (GIST): an analysis based on the GIST registry. Ann. Surg. Oncol. 2015, 22:232-239.
64. Jenssen C., Barreiros A.P., Will U., Burmester E., Schmidtmann I., Eckardt A.J. German survey on EUS-guided diagnosis and management of gastrointestinal stromal tumors (GISTs)-evidence or gut-feeling?. Ultraschall in der Medizin (Stuttgart, Germany: 1980) 2015, 36:494-500.
65. Lasota J., Kuban W., Wardelmann E., Debiec-Rychter M., Merkelbach-Bruse S., Sciot R., et al. KIT codon 558 insertions in gastrointestinal stromal tumors. Analysis of 17 rare KIT mutants. Hum. Pathol. 2008, 39:1728-1736.
66. Lasota J., Wasag B., Steigen S.E., Limon J., Miettinen M. Improved detection of KIT exon 11 duplications in formalin-fixed, paraffin-embedded gastrointestinal stromal tumors. J. Mol. Diagn. 2007, 9:89-94.
67. Rossi S., Gasparotto D., Miceli R., Toffolatti L., Gallina G., Scaramel E., et al. KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study. Am. J. Surg. Pathol. 2015, 39:922-930.
68. Cioffi A., Maki R.G. GI stromal tumors: 15 years of lessons from a rare cancer. J. Clin. Oncol. 2015, 33:1849-1854.
69. Lee C.K., Goldstein D., Gibbs E., Joensuu H., Zalcberg J., Verweij J., et al. Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib. Eur. J. Cancer 2015, 51:852-860.
70. Bischof D.A., Kim Y., Behman R., Karanicolas P.J., Quereshy F.A., Blazer D.G., et al. A nomogram to predict disease-free survival after surgical resection of GIST. J. Gastrointest. Surg. 2014, 18:2123-2129.
71. Harlan L.C., Eisenstein J., Russell M.C., Stevens J.L., Cardona K. Gastrointestinal stromal tumors: treatment patterns of a population-based sample. J. Surg. Oncol. 2015, 111:702-707.
72. Guller U., Tarantino I., Cerny T., Schmied B.M., Warschkow R. Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor. BMC Cancer 2015, 15:557.
73. Seker M., Sevinc A., Yildiz R., Cihan S., Kaplan M.A., Gokdurnali A., et al. Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from Turkey. Hepatogastroenterology 2013, 60:768-775.
74. Brady-West D., Blake G. Clinicopathological features and outcome of gastrointestinal stromal tumors in an Afro-Caribbean population. J. Nat. Med. Assoc. 2012, 104:72-77.
75. Tesfay W., Komminoth P., Schneider J. Gastrointestinal stromal tumors in Addis Ababa, Ethiopia. Ethiop. Med. J. 2011, 49:43-50.
76. Bokhary R.Y., Al-Maghrabi J.A. Gastrointestinal stromal tumors in western Saudi Arabia. Saudi Med. J. 2010, 31:437-441.
77. Abdulkareem F.B., Rotimi O., Elesha S.O., Banjo A.A. Immunophenotyping of gastrointestinal mesenchymal tumours in Lagos, Nigeria. West Afr. J. Med. 2009, 28:358-362.
78. Rubin J.L., Sanon M., Taylor D.C., Coombs J., Bollu V., Sirulnik L. Epidemiology, survival, and costs of localized gastrointestinal stromal tumors. Int. J. Gen. Med. 2011, 4:121-130.